ACUTE MYELOID LEUKEMIA MEETING


Ravenna, October 27, 2017

SESSION I

Leukemia biology: from science to clinical application

Moderators: F. Lanza, A.L.Molinari

C. Agostinelli

Updates of the WHO classification 2016: impact on the diagnosis of acute myeloid leukemia

Therapy of AML

A.K. Burnett

Frontline induction therapy in 2017

SESSION II

Targeted specific treatments

Moderators: G. Musuraca, P. Tosi

L. Cicconi

Acute promyelocytic leukemia

M.S. Tallman

Epigenetic target therapy in AML

A. Curti

Evolving role of immunotherapy

SESSION III

Post remission therapy

Moderators: M.B. Giannini, E. Zuffa

C. Papayannidis

Post remission therapy and "maintenance"?

Tools for MRD in AML

F. Buccisano

Flow cytometry

G. Saglio

Molecular markers

F. Saraceni

Autologous transplantation in AML